VasoGnosis

VasoGnosis was a private healthtech company that developed AI-powered diagnostic and surgical planning software for cerebrovascular and neurovascular disease, with a particular focus on brain aneurysms. Its products were described as cloud-based tools that automated 3D reconstruction, diagnostic analysis, and simulation-based surgical planning for neurosurgeons and interventional neuroradiologists. The company positioned its software as a clinical workflow support platform rather than a therapeutics developer, combining deep learning, medical imaging analysis, and computational modeling. Public company-profile sources indicate the business was founded in 2019 in Milwaukee, Wisconsin and later became inactive or out of business by 2022. Because the company appears to have been a software/device-focused health company rather than a drug developer, it does not have a conventional biotech pipeline of therapeutic candidates.